364 filings
Page 2 of 19
UPLOAD
ATXI
Avenue Therapeutics Inc
29 Jan 24
Letter from SEC
12:00am
S-3
ATXI
Avenue Therapeutics Inc
Shelf registration
24 Jan 24
4:11pm
PRE 14C
ATXI
Avenue Therapeutics Inc
17 Jan 24
Preliminary information
5:05pm
8-K
ATXI
Avenue Therapeutics Inc
12 Jan 24
Submission of Matters to a Vote of Security Holders
6:01am
8-K
ATXI
Avenue Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
4
ATXI
Avenue Therapeutics Inc
3 Jan 24
Change in insider ownership
4:27pm
SC 13G/A
Sabby Management, LLC
2 Jan 24
AVENUE THERAPEUTICS / SABBY MANAGEMENT ownership change
3:45pm
SC 13G/A
Robert L Davidow
13 Dec 23
AVENUE THERAPEUTICS / Davidow Robert L ownership change
4:03pm
4
Robert L Davidow
13 Dec 23
AVENUE THERAPEUTICS / Robert L Davidow ownership change
4:02pm
SC 13G
Robert L Davidow
28 Nov 23
AVENUE THERAPEUTICS / Davidow Robert L ownership change
4:05pm
3
Robert L Davidow
28 Nov 23
AVENUE THERAPEUTICS / Robert L Davidow ownership change
4:01pm
8-K
ATXI
Avenue Therapeutics Inc
24 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:19pm
10-Q
2023 Q3
ATXI
Avenue Therapeutics Inc
Quarterly report
13 Nov 23
4:15pm
8-K
ATXI
Avenue Therapeutics Inc
13 Nov 23
Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
4:10pm
8-K
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
ATXI
Avenue Therapeutics Inc
2 Nov 23
Prospectus supplement with pricing info
9:00am
EFFECT
ATXI
Avenue Therapeutics Inc
1 Nov 23
Notice of effectiveness
12:15am
CORRESP
ATXI
Avenue Therapeutics Inc
30 Oct 23
Correspondence with SEC
12:00am
CORRESP
ATXI
Avenue Therapeutics Inc
30 Oct 23
Correspondence with SEC
12:00am
CORRESP
ATXI
Avenue Therapeutics Inc
27 Oct 23
Correspondence with SEC
12:00am